Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up
- PMID: 1757079
- DOI: 10.1111/j.1365-2559.1991.tb00229.x
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up
Abstract
Morphological assessment of the degree of differentiation has been shown in numerous studies to provide useful prognostic information in breast cancer, but until recently histological grading has not been accepted as a routine procedure, mainly because of perceived problems with reproducibility and consistency. In the Nottingham/Tenovus Primary Breast Cancer Study the most commonly used method, described by Bloom & Richardson, has been modified in order to make the criteria more objective. The revised technique involves semiquantitative evaluation of three morphological features--the percentage of tubule formation, the degree of nuclear pleomorphism and an accurate mitotic count using a defined field area. A numerical scoring system is used and the overall grade is derived from a summation of individual scores for the three variables: three grades of differentiation are used. Since 1973, over 2200 patients with primary operable breast cancer have been entered into a study of multiple prognostic factors. Histological grade, assessed in 1831 patients, shows a very strong correlation with prognosis; patients with grade I tumours have a significantly better survival than those with grade II and III tumours (P less than 0.0001). These results demonstrate that this method for histological grading provides important prognostic information and, if the grading protocol is followed consistently, reproducible results can be obtained. Histological grade forms part of the multifactorial Nottingham prognostic index, together with tumour size and lymph node stage, which is used to stratify individual patients for appropriate therapy.
Republished in
-
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.Histopathology. 2002 Sep;41(3A):154-61. Histopathology. 2002. PMID: 12405947 No abstract available.
Comment in
-
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403-410.Histopathology. 2002 Sep;41(3A):151-2, discussion 152-3. Histopathology. 2002. PMID: 12405945 No abstract available.
Similar articles
-
The assessment of histological differentiation in breast cancer.Aust N Z J Surg. 1984 Feb;54(1):11-5. doi: 10.1111/j.1445-2197.1984.tb06677.x. Aust N Z J Surg. 1984. PMID: 6586161
-
The prognostic effect of histological tumor grade in node-negative breast cancer patients.Breast Cancer Res Treat. 1993;25(3):235-45. doi: 10.1007/BF00689838. Breast Cancer Res Treat. 1993. PMID: 8369525 Clinical Trial.
-
Role of mitotic counts in the grading and prognosis of the breast cancer.Indian J Pathol Microbiol. 2002 Jul;45(3):247-54. Indian J Pathol Microbiol. 2002. PMID: 12785160
-
Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer.Breast Cancer. 2006;13(3):249-253. doi: 10.2325/jbcs.13.249. Breast Cancer. 2006. PMID: 16929117 Review.
-
Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors.APMIS Suppl. 1998;79:1-34. APMIS Suppl. 1998. PMID: 9645191 Review.
Cited by
-
Development and Validation of an MRI Radiomics-Based Signature to Predict Histological Grade in Patients with Invasive Breast Cancer.Breast Cancer (Dove Med Press). 2022 Oct 14;14:335-342. doi: 10.2147/BCTT.S380651. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 36262333 Free PMC article.
-
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects.Oncotarget. 2015 Feb 28;6(6):4299-314. doi: 10.18632/oncotarget.3012. Oncotarget. 2015. PMID: 25726524 Free PMC article.
-
Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor.PLoS One. 2013 Apr 19;8(4):e61591. doi: 10.1371/journal.pone.0061591. Print 2013. PLoS One. 2013. PMID: 23620774 Free PMC article.
-
Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis.J Biol Chem. 2012 Oct 12;287(42):35646-35657. doi: 10.1074/jbc.M112.377481. Epub 2012 Jul 30. J Biol Chem. 2012. PMID: 22847003 Free PMC article.
-
The Uncontrolled Sialylation is Related to Chemoresistant Metastatic Breast Cancer.Pathol Oncol Res. 2016 Oct;22(4):869-73. doi: 10.1007/s12253-016-0057-6. Epub 2016 Apr 1. Pathol Oncol Res. 2016. PMID: 27037559
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical